Navigation Links
Idenix to Host Conference Call Discussing Fourth Quarter and Year End 2010 Financial Results
Date:2/14/2011

CAMBRIDGE, Mass., Feb. 14, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the fourth quarter and year end of 2010 on Monday, February 28, 2011 after U.S. financial markets close.

Idenix management will host a conference call at 4:30 p.m. ET on Monday, February 28, 2011 to discuss the company's financial results for the fourth quarter and year end of 2010 and provide an update on the company's development programs.

To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 44647149 or to listen to a live webcast go to "Calendar of Events" in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from February 28, 2011, 6:30 p.m. ET until March 14, 2011, 11:59 p.m. ET.  To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 44647149. An archived webcast will also be available for two weeks after the call on the Idenix website.

About IdenixIdenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.Idenix Pharmaceuticals Contacts:Kelly Barry (617) 995-9033  (media)Eric Hoffman (617) 224-4485 (investors)
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
2. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
3. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
5. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
6. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
7. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
8. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
9. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
10. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Influenza will affect as many as 200,000 people ... United States as high as 49,000 people.  The ... from person to person in respiratory droplets of coughs and ... death, but kills much fewer people each year than the ... fluids including sweat, saliva, blood and other bodily fluids. The ...
(Date:10/22/2014)... , Oct. 22, 2014 InVivo Therapeutics Holdings ... is revolutionizing spinal cord injury (SCI) treatment ... shown to outperform in tissue regrowth in the spinal ... Made from an FDA approved polymer, the scaffold ultimately ... harmless to the human body. NVIV has recently attracted ...
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately ... bacterial infections, microbial biofilms, and chronic wounds, announced that ... directors. , Dr. Sinskey is a ... Institute of Technology, or MIT. He has been a ... also holds positions as Co-Director of the Malaysia-MIT Biotechnology ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... fertilization (IVF) are only about half as likely as white ... new research indicates, and the racial disparity persists even when ... percent of white patients became pregnant after IVF, compared to ... 4,000 IVF cycles over two years to tease out the ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter , ... young adult men may lead to increased blood pressure, according ... a similar rise in blood pressure for young adult women ... young adult women drank lightly or moderately, their risk of ... "This finding parallels studies in older adult men and ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 (HealthDay News) -- ... NBC News in Liberia has cleared the virus from ... Medical Center in Omaha, where he had been treated for the ... confirmed by the U.S. Centers for Disease Control and Prevention found ... NBC News reported Tuesday night. "Recovering from Ebola is ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3
... of Miami (UM) Department of Psychology participated in a multi-site ... Spectrum Disorder (ASD). The study is one of the first ... with autism. The findings are published online in the ... Disorders . The report concludes the first phase ...
... By Serena Gordon HealthDay Reporter , THURSDAY, May ... year is especially tough, say allergy experts. "Everyone ... the worst year ever for allergies," said Dr. David Rosenstreich, ... Center in New York City. But this year those ...
... French . , Montreal, May 19, 2010 Caring ... a taxing experience marked by personal sacrifices and psychological problems. ... the University of British Columbia has found family caregivers can ... symptoms unless they refocus their priorities and lighten their ...
... A University of Missouri researcher has found that eating ... satiety and reduces hunger throughout the day. In addition, ... that eating a protein-rich breakfast reduces the brain signals ... knows that eating breakfast is important, but many people ...
... Crohn,s patients in a research study at Penn ... a chronic inflammatory condition of the gastrointestinal tract ... loss. Treatments for Crohn,s disease are designed to ... rare but serious side effects, including infections and ...
... Dozens of studies on whether moderate exercise can ... up to an apparent contradiction: it seems to work ... out in treatment trials. A new study may explain ... The explanation suggested in the results of research led ...
Cached Medicine News:Health News:Validating preschool programs for children with autism 2Health News:Springtime and the Sneezin' Is Easy 2Health News:Springtime and the Sneezin' Is Easy 3Health News:Bearing through it: How caregivers of mentally ill kin can cope 2Health News:Eat a protein-rich breakfast to reduce food cravings, prevent overeating later, researcher finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2Health News:Exercise helps women fight smoking cravings, but effect is short-lived 2
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Occipital Mandibular Immobilizer) A completely adjustable ... or hypertension positioning and immobilization. Offers ... Philadelphia™ collar and a halo-type brace.,Mandibular ... Removable chin plate allows for patient ...
Ezy Wrap® Economy Contour Cervical Collar Medium-density urethane foam. Synthetic white stockinette cover. Reverses for flexion or extension. (Contact closure. Hand wash. Air dry. 10/pack.)...
... Exo-Static™ Collar for cervical ... positions. Automatic adjustment allows widening ... lowered under chin. Velcro® fasterner.,Exo-Static™ ... backward movement, even in neutral ...
Medicine Products: